I have been a buyer at these prices. Been on the sidelines for a long time. Back in. Looks good for the year ahead. Been wrong before but .
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
PDI Chris Judd’s Talk Ya Book: Predictive Discovery finally coming to its 'pointy end' - and it's gunning for gold